Thermo Fisher Scientific Stock London S.E.

Equities

0R0H

US8835561023

Advanced Medical Equipment & Technology

Market Closed - London S.E. 11:11:58 2024-07-05 am EDT 5-day change 1st Jan Change
538.5 USD +154.38% Intraday chart for Thermo Fisher Scientific -2.40% +1.56%
Sales 2024 * 43.01B Sales 2025 * 46.05B Capitalization 204B
Net income 2024 * 6.18B Net income 2025 * 6.96B EV / Sales 2024 * 5.29 x
Net Debt 2024 * 23.19B Net Debt 2025 * 19.14B EV / Sales 2025 * 4.85 x
P/E ratio 2024 *
33.7 x
P/E ratio 2025 *
29 x
Employees 122,000
Yield 2024 *
0.28%
Yield 2025 *
0.3%
Free-Float 86.04%
More Fundamentals * Assessed data
Dynamic Chart
Evercore ISI Cuts Price Target on Thermo Fisher Scientific to $600 From $615, Maintains Outperform Rating MT
Verici Dx hails milestone payment in deal with Thermo Fisher AN
Thermo Fisher Scientific Inc.(NYSE:TMO) dropped from Russell Top 200 Growth Index CI
Thermo Fisher Scientific Inc.(NYSE:TMO) dropped from Russell 3000 Growth Index CI
Thermo Fisher Scientific Inc.(NYSE:TMO) dropped from Russell 3000E Growth Index CI
Thermo Fisher Scientific Inc.(NYSE:TMO) dropped from Russell 1000 Growth Index CI
Thermo Fisher Scientific Inc.(NYSE:TMO) dropped from Russell 1000 Growth-Defensive Index CI
Thermo Fisher Scientific Inc. Expands Clinical Research Laboratory in Kentucky CI
Barclays Adjusts Price Target on Thermo Fisher Scientific to $600 From $615 MT
Labguru Announces New Distribution Partnership with Thermo Fisher Scientific of its Electronic Lab Notebook Module to Help Streamline Life Sciences Research CI
Thermo Fisher Scientific Introduces the Only Fully Automated Plasmid Purification System to Help Accelerate Discovery and Development of Therapies CI
RBC Trims Price Target on Thermo Fisher Scientific to $660 From $662, Keeps Outperform Rating MT
Thermo Fisher Scientific Inc. Expands Clinical Research Laboratory in Wisconsin CI
Thermo Fisher Scientific Inc., National University Hospital, Singapore and Mirxes Collaborates to Enhance Access to Advanced Genomic Testing for Early Cancer Detection in Singapore CI
Verici Dx plc Announces Successful Transfer of Urine Samples to Thermo Fisher Scientific CI
More news
1 day+154.38%
1 week-2.40%
Current month-2.06%
1 month-5.51%
3 months-7.05%
6 months+0.66%
Current year+1.56%
More quotes
1 week
531.99
Extreme 531.99
557.82
1 month
531.99
Extreme 531.99
585.87
Current year
527.15
Extreme 527.15
603.14
1 year
416.66
Extreme 416.655
603.14
3 years
416.66
Extreme 416.655
671.75
5 years
256.47
Extreme 256.4708
671.75
10 years
200.18
Extreme 200.18
671.75
More quotes
Managers TitleAgeSince
Chief Executive Officer 56 01-10-31
Director of Finance/CFO 57 01-05-31
Chief Tech/Sci/R&D Officer - 18-12-31
Members of the board TitleAgeSince
Chief Executive Officer 56 01-10-31
Director/Board Member 67 12-03-29
Director/Board Member 62 22-02-28
More insiders
Date Price Change Volume
24-07-05 538.5 +154.38% 786
24-07-03 535.8 -0.03% 2,111
24-07-02 536 -0.95% 2,844
24-07-01 541.1 -1.58% 451
24-06-28 549.8 -0.35% 1,333

Delayed Quote London S.E., July 05, 2024 at 11:11 am EDT

More quotes
Thermo Fisher Scientific Inc. specializes in the design, manufacturing and marketing of laboratory and scientific equipments. Net sales (including intragroup) break down by family of products as follows: - laboratory equipments (70%). Moreover, the group proposes chemical products (reagents, solvent, salts, etc.), consumable products (tubes, funnels, vials, etc.), as well as conditioning, warehousing, storage, etc.; - diagnostics equipment and products (15.3%); - scientific analysis equipments (14.7%): analyzer (of water, gas, grounds, etc.), mass spectrometers, molecular spectroscopes, microscopes, manometers, samplers, microbiology equipments, reactive agents, etc. Net sales break down by source of income into products sales (78.5%) and services (21.5%). Net sales break down geographically as follows: North America (53%), Europe (25.7%), Asia-Pacific (18.1%) and others (3.2%).
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
26
Last Close Price
535.6 USD
Average target price
628.2 USD
Spread / Average Target
+17.29%
Consensus